ClearArc Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $1.22M | Sell |
3,741
-1,743
| -32% | -$566K | 0.47% | 50 |
|
2019
Q3 | $1.6M | Buy |
5,484
+50
| +0.9% | +$14.6K | 0.46% | 49 |
|
2019
Q2 | $1.6M | Sell |
5,434
-770
| -12% | -$226K | 0.47% | 48 |
|
2019
Q1 | $1.7M | Sell |
6,204
-180
| -3% | -$49.3K | 0.46% | 55 |
|
2018
Q4 | $1.43M | Sell |
6,384
-2,926
| -31% | -$655K | 0.43% | 56 |
|
2018
Q3 | $2.27M | Buy |
9,310
+68
| +0.7% | +$16.6K | 0.3% | 84 |
|
2018
Q2 | $1.91M | Buy |
9,242
+71
| +0.8% | +$14.7K | 0.27% | 92 |
|
2018
Q1 | $1.89M | Buy |
9,171
+60
| +0.7% | +$12.4K | 0.29% | 87 |
|
2017
Q4 | $1.73M | Buy |
9,111
+51
| +0.6% | +$9.68K | 0.23% | 98 |
|
2017
Q3 | $1.71M | Buy |
9,060
+188
| +2% | +$35.6K | 0.26% | 91 |
|
2017
Q2 | $1.55M | Buy |
8,872
+49
| +0.6% | +$8.55K | 0.25% | 101 |
|
2017
Q1 | $1.36M | Sell |
8,823
-60
| -0.7% | -$9.22K | 0.23% | 110 |
|
2016
Q4 | $1.25M | Sell |
8,883
-88
| -1% | -$12.4K | 0.23% | 113 |
|
2016
Q3 | $1.43M | Buy |
8,971
+32
| +0.4% | +$5.09K | 0.27% | 96 |
|
2016
Q2 | $1.32M | Sell |
8,939
-47
| -0.5% | -$6.95K | 0.26% | 98 |
|
2016
Q1 | $1.27M | Sell |
8,986
-45
| -0.5% | -$6.37K | 0.27% | 96 |
|
2015
Q4 | $1.28M | Buy |
9,031
+85
| +1% | +$12.1K | 0.27% | 97 |
|
2015
Q3 | $1.09M | Sell |
8,946
-159
| -2% | -$19.4K | 0.23% | 118 |
|
2015
Q2 | $1.18M | Buy |
9,105
+1,041
| +13% | +$135K | 0.22% | 124 |
|
2015
Q1 | $1.08M | Buy |
8,064
+89
| +1% | +$12K | 0.22% | 130 |
|
2014
Q4 | $999K | Buy |
7,975
+189
| +2% | +$23.7K | 0.2% | 142 |
|
2014
Q3 | $948K | Buy |
7,786
+174
| +2% | +$21.2K | 0.21% | 140 |
|
2014
Q2 | $898K | Sell |
7,612
-477
| -6% | -$56.3K | 0.21% | 139 |
|
2014
Q1 | $973K | Buy |
8,089
+765
| +10% | +$92K | 0.24% | 126 |
|
2013
Q4 | $816K | Buy |
7,324
+121
| +2% | +$13.5K | 0.21% | 138 |
|
2013
Q3 | $664K | Sell |
7,203
-213
| -3% | -$19.6K | 0.19% | 152 |
|
2013
Q2 | $628K | Buy |
+7,416
| New | +$628K | 0.17% | 157 |
|